P01-CA97296/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	2
2003	3
2004	5
2005	2
2006	4
2007	4
2008	5
2009	3
2010	4
2011	3
2012	8
2013	5
2014	3
2015	2
2024	0

1

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, Duggan R, Wang Y, Barber GN, Fitzgerald KA, Alegre ML, Gajewski TF. Woo SR, et al. Immunity. 2014 Nov 20;41(5):830-42. doi: 10.1016/j.immuni.2014.10.017. Epub 2014 Nov 5. Immunity. 2014. PMID: 25517615 Free PMC article.

2

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo SR, Lemmens E, Banda T, Leong JJ, Metchette K, Dubensky TW Jr, Gajewski TF. Corrales L, et al. Cell Rep. 2015 May 19;11(7):1018-30. doi: 10.1016/j.celrep.2015.04.031. Epub 2015 May 7. Cell Rep. 2015. PMID: 25959818 Free PMC article.

3

Specificity in cancer immunotherapy.

Schietinger A, Philip M, Schreiber H. Schietinger A, et al. Semin Immunol. 2008 Oct;20(5):276-85. doi: 10.1016/j.smim.2008.07.001. Epub 2008 Aug 5. Semin Immunol. 2008. PMID: 18684640 Free PMC article. Review.

4

CD4+ T cell matters in tumor immunity.

Velders MP, Markiewicz MA, Eiben GL, Kast WM. Velders MP, et al. Int Rev Immunol. 2003 Mar-Apr;22(2):113-40. doi: 10.1080/08830180305220. Int Rev Immunol. 2003. PMID: 12962272 Review.

5

Targeting cancer-specific mutations by T cell receptor gene therapy.

Blankenstein T, Leisegang M, Uckert W, Schreiber H. Blankenstein T, et al. Curr Opin Immunol. 2015 Apr;33:112-9. doi: 10.1016/j.coi.2015.02.005. Epub 2015 Feb 27. Curr Opin Immunol. 2015. PMID: 25728991 Free PMC article. Review.

6

HPV protein/peptide vaccines: from animal models to clinical trials.

Fausch SC, Da Silva DM, Eiben GL, Le Poole IC, Kast WM. Fausch SC, et al. Front Biosci. 2003 Jan 1;8:s81-91. doi: 10.2741/1009. Front Biosci. 2003. PMID: 12456298 Review.

7

Inflammation as a tumor promoter in cancer induction.

Philip M, Rowley DA, Schreiber H. Philip M, et al. Semin Cancer Biol. 2004 Dec;14(6):433-9. doi: 10.1016/j.semcancer.2004.06.006. Semin Cancer Biol. 2004. PMID: 15489136 Review.

8

Costimulatory and coinhibitory receptors in anti-tumor immunity.

Driessens G, Kline J, Gajewski TF. Driessens G, et al. Immunol Rev. 2009 May;229(1):126-44. doi: 10.1111/j.1600-065X.2009.00771.x. Immunol Rev. 2009. PMID: 19426219 Free PMC article. Review.

9

Type I interferon response and innate immune sensing of cancer.

Fuertes MB, Woo SR, Burnett B, Fu YX, Gajewski TF. Fuertes MB, et al. Trends Immunol. 2013 Feb;34(2):67-73. doi: 10.1016/j.it.2012.10.004. Epub 2012 Oct 31. Trends Immunol. 2013. PMID: 23122052 Free PMC article. Review.

10

Therapeutic vaccination for HPV induced cervical cancers.

Brinkman JA, Hughes SH, Stone P, Caffrey AS, Muderspach LI, Roman LD, Weber JS, Kast WM. Brinkman JA, et al. Dis Markers. 2007;23(4):337-52. doi: 10.1155/2007/245146. Dis Markers. 2007. PMID: 17627067 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year